Cann American Corp. (CNNA)
Cann American Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Orlando, FL, US. The stock last traded at $0.01, down 9.09% on the session, giving a market capitalisation of $4.4M. On trailing twelve-month figures it carries a trailing P/E of 0.49, a net margin of 0.0%. Its beta of -0.86 implies it has historically moved less than the broad market.
Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 and headquartered in Cloverdale, California, Cann American Corp. previously operated as Canamed4Pets, Inc. before officially rebranding in December 2019.
Cann American Corp. is most often compared with the following Healthcare names: